Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynein, cytoplasmic, light polypeptide 1 pseudogene (ENSG00000234001) is a nonfunctional DNA segment that retains high sequence similarity to the functional dynein light chain gene but is incapable of encoding a functional protein product due to disabling mutations. It is classified as a pseudogene: a remnant of a once-functional gene that has lost coding capacity through evolutionary processes. While some pseudogenes are occasionally transcribed and may participate in gene regulation as noncoding RNAs, there is no evidence that this particular pseudogene serves such a function. It has no known role as a drug target, biomarker, or disease-associated gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynein, cytoplasmic, light polypeptide 1 pseudogene (DNCL1 pseudogene).